Live Nasdaq Composite: Market Sentiment Sours as Investors Question Big Tech Earnings and Oil Pulls Back From $100

Investing

Investing Articles

All Investing Articles

62202 Articles

David Moadel | Apr 23, 2026 at 12:55 PM EDT

BofA Just Upgraded Texas Instruments to Buy With a $320 Target. Is This the Ultimate Industrial AI Chip Play?

Analysts at Bank of America just made the bull case for Texas Instruments (NASDAQ:TXN | TXN Price Prediction), with analyst…

Rich Duprey | Apr 23, 2026 at 12:50 PM EDT

Finally. Marijuana Gets Reclassified, but Are Pot Stocks Still Too Risky?

Markets don’t usually wait for permission — they anticipate it. That’s why cannabis stocks jumped ahead of the official news…

David Moadel | Apr 23, 2026 at 12:50 PM EDT

ServiceNow Just Plunged 18% on Earnings. Is This a Once-in-a-Cycle Buying Opportunity?

Shares of ServiceNow (NYSE:NOW | NOW Price Prediction) plunged roughly 18% on Thursday after the enterprise software giant’s Q1 2026…

David Moadel | Apr 23, 2026 at 12:45 PM EDT

Capital One Missed Earnings and Truist Cut Its Target. Should You Buy the Dip on This Credit Card Giant?

Truist Securities trimmed its price target on Capital One Financial (NYSE:COF | COF Price Prediction) to $255 from $275 on…

Joel South | Apr 23, 2026 at 12:43 PM EDT

Jim Cramer Says Tim Cook Built Something No Other CEO Has: A Device People Think Is Their Friend

Jim Cramer singled out Tim Cook on Tuesday’s Mad Money for achieving something rare in modern business: building a company…

David Moadel | Apr 23, 2026 at 12:41 PM EDT

ServiceNow Got Hammered by Wall Street After Earnings. Is the Selloff a Gift for Patient Buyers?

Shares of ServiceNow (NYSE:NOW | NOW Price Prediction) stock were hammered after the company’s latest earnings print, with at least…

David Moadel | Apr 23, 2026 at 12:34 PM EDT

JPMorgan Just Crowned Lam Research With a $315 Target. Is the Chip Equipment Supercycle Just Getting Started?

JPMorgan analyst Harlan Sur raised his price target on Lam Research (NASDAQ:LRCX | LRCX Price Prediction) stock to $315 from…

David Beren | Apr 23, 2026 at 12:21 PM EDT

The Last Cannabis ETFs Worth Your Money: Why Most Failed and 3 Are Still Trading

Cannabis ETFs entered 2026 after multiple fund closures, stalled federal reform, and a prolonged multi‑year drawdown in underlying equities. The…

David Moadel | Apr 23, 2026 at 12:18 PM EDT

DZ Bank Just Launched Palantir at Buy With a $175 Target: The AI Darling Gains Another Believer

Analysts at DZ Bank just put their stamp of approval on one of Wall Street’s most-watched AI names, launching coverage…

David Moadel | Apr 23, 2026 at 12:13 PM EDT

Barclays Holds the Line on Tesla After Capex Shock: Is the Robotaxi Story Worth the Spend?

Barclays held its Equal Weight rating on Tesla (NASDAQ:TSLA | TSLA Price Prediction) stock with a $360 price target following…

Rich Duprey | Apr 23, 2026 at 11:27 AM EDT

Tesla Isn’t an EV Stock Anymore: How Should Investors Value It?

The stock market loves a clean story — growth company, value play, or cyclical rebound. Tesla (NASDAQ:TSLA | TSLA Price…

Trey Thoelcke | Apr 23, 2026 at 11:15 AM EDT

One Year Later: Our ‘No-Brainer’ Rigetti Call Doubled. What to Do Now.

One year ago, 24/7 Wall St. published a buy-the-dip call on Rigetti Computing (NASDAQ: RGTI). The thesis rested on Nvidia’s pivot…

Rich Duprey | Apr 23, 2026 at 11:05 AM EDT

Yep, the Data Center Boom Is Taking Texas Instruments With It

Texas Instruments (NASDAQ:TXN | TXN Price Prediction) just delivered the kind of quarter that validates the entire data center infrastructure…

David Moadel | Apr 23, 2026 at 11:00 AM EDT

Tesla Slides 4%: Investors Digest Capex Ramp, Tempered Self-Driving Outlook

Shares of Tesla (NASDAQ:TSLA | TSLA Price Prediction) are down 4% in Thursday morning trading, changing hands near $370 after…

David Beren | Apr 23, 2026 at 10:55 AM EDT

Treasury and Bond ETFs Are Back in Fashion: Here’s What to Own in April 2026

Volatility spiked in late March when the VIX reached 31.05 on March 27, 2026, before easing back to roughly 19.50,…

1 … 29 30 31 32 33 … 124

Investing Articles

All Investing Articles

BofA Just Upgraded Texas Instruments to Buy With a $320 Target. Is This the Ultimate Industrial AI Chip Play?

Finally. Marijuana Gets Reclassified, but Are Pot Stocks Still Too Risky?

ServiceNow Just Plunged 18% on Earnings. Is This a Once-in-a-Cycle Buying Opportunity?

Capital One Missed Earnings and Truist Cut Its Target. Should You Buy the Dip on This Credit Card Giant?

Jim Cramer Says Tim Cook Built Something No Other CEO Has: A Device People Think Is Their Friend

ServiceNow Got Hammered by Wall Street After Earnings. Is the Selloff a Gift for Patient Buyers?

JPMorgan Just Crowned Lam Research With a $315 Target. Is the Chip Equipment Supercycle Just Getting Started?

The Last Cannabis ETFs Worth Your Money: Why Most Failed and 3 Are Still Trading

DZ Bank Just Launched Palantir at Buy With a $175 Target: The AI Darling Gains Another Believer

Barclays Holds the Line on Tesla After Capex Shock: Is the Robotaxi Story Worth the Spend?

Tesla Isn’t an EV Stock Anymore: How Should Investors Value It?

One Year Later: Our ‘No-Brainer’ Rigetti Call Doubled. What to Do Now.

Yep, the Data Center Boom Is Taking Texas Instruments With It

Tesla Slides 4%: Investors Digest Capex Ramp, Tempered Self-Driving Outlook

Treasury and Bond ETFs Are Back in Fashion: Here’s What to Own in April 2026

Live Nasdaq Composite: Market Sentiment Sours as Investors Question Big Tech Earnings and Oil Pulls Back From $100

A Second Software Crash Could Erupt — And New Disruptive AI Applications Might Spark It

A 68-Year-Old With $850,000 in a Traditional IRA Is Sitting on a Six-Figure Tax Bill. Here’s How Retirees Shrink It.

Medicare’s Free ‘Annual Wellness Visit’ Isn’t a Physical. Ask the Wrong Question and a Bill Follows.

A 68-Year-Old With $850,000 in a Traditional IRA Is Sitting on a Six-Figure Tax Bill. Here's How Retirees Shrink It.

Medicare's Free 'Annual Wellness Visit' Isn't a Physical. Ask the Wrong Question and a Bill Follows.

1 Ultra-Cheap ETF to Buy With $1,000 and Never Think About Again

A Second Software Crash Could Erupt — And New Disruptive AI Applications Might Spark It

Investing Articles

All Investing Articles

BofA Just Upgraded Texas Instruments to Buy With a $320 Target. Is This the Ultimate Industrial AI Chip Play?

Finally. Marijuana Gets Reclassified, but Are Pot Stocks Still Too Risky?

ServiceNow Just Plunged 18% on Earnings. Is This a Once-in-a-Cycle Buying Opportunity?

Capital One Missed Earnings and Truist Cut Its Target. Should You Buy the Dip on This Credit Card Giant?

Jim Cramer Says Tim Cook Built Something No Other CEO Has: A Device People Think Is Their Friend

ServiceNow Got Hammered by Wall Street After Earnings. Is the Selloff a Gift for Patient Buyers?

JPMorgan Just Crowned Lam Research With a $315 Target. Is the Chip Equipment Supercycle Just Getting Started?

The Last Cannabis ETFs Worth Your Money: Why Most Failed and 3 Are Still Trading

DZ Bank Just Launched Palantir at Buy With a $175 Target: The AI Darling Gains Another Believer

Barclays Holds the Line on Tesla After Capex Shock: Is the Robotaxi Story Worth the Spend?

Tesla Isn’t an EV Stock Anymore: How Should Investors Value It?

One Year Later: Our ‘No-Brainer’ Rigetti Call Doubled. What to Do Now.

Yep, the Data Center Boom Is Taking Texas Instruments With It

Tesla Slides 4%: Investors Digest Capex Ramp, Tempered Self-Driving Outlook

Treasury and Bond ETFs Are Back in Fashion: Here’s What to Own in April 2026

Live Nasdaq Composite: Market Sentiment Sours as Investors Question Big Tech Earnings and Oil Pulls Back From $100

A Second Software Crash Could Erupt — And New Disruptive AI Applications Might Spark It

A 68-Year-Old With $850,000 in a Traditional IRA Is Sitting on a Six-Figure Tax Bill. Here’s How Retirees Shrink It.

Medicare’s Free ‘Annual Wellness Visit’ Isn’t a Physical. Ask the Wrong Question and a Bill Follows.

Featured Reads

A 68-Year-Old With $850,000 in a Traditional IRA Is Sitting on a Six-Figure Tax Bill. Here's How Retirees Shrink It.

Medicare's Free 'Annual Wellness Visit' Isn't a Physical. Ask the Wrong Question and a Bill Follows.